Breaking Down AI's Role in Genomics and Polygenic Risk Prediction - with Dan Elton of the National Human Genome Research Institute

Breaking Down AI's Role in Genomics and Polyg...

Daniel FaggellaDaniel Faggella

Up next

Why Ensemble Architectures Win Against Real-Time Voice Risk - with Mike Pappas of Modulate

The contact center is shifting from a service channel to a primary point of fraud, where text‑based systems fail to catch the signals that surface only in live voice. In this episode, Mike Pappas, CEO & Co‑Founder at Modulate, joins Emerj's Nick Gertsch to examine how audio‑nativ ...  Show more

 . 28min 36sec
From Multi Agent Systems to Institutional Learning in the Enterprise - with Papi Menon of Outshift by Cisco

A growing number of enterprises are discovering that early agent wins don't translate into scale because agents can connect but cannot yet share context or improve as a coordinated system. In this episode, Papi Menon, Vice President of Product Management and Chief Product Officer ...  Show more

 . 31min 25sec

Recommended Episodes

The AI Will See You Now: Exploring Biomedical AI and Google’s Med-PaLM2 With Karan Singhal
No Priors: Artificial Intelligence | Technology | Startups

What if AI could revolutionize healthcare with advanced language learning models? Sarah and Elad welcome Karan Singhal, Staff Software Engineer at Google Research, who specializes in medical AI and the development of MedPaLM2. On this episode, Karan emphasizes the importance of s ...  Show more

 . 42min 48sec
#309 ‒ AI in medicine: its potential to revolutionize disease prediction, diagnosis, and outcomes, causes for concern in medicine and beyond, and more | Isaac Kohane, M.D., Ph.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/?utm_s ...

  Show more

 . 1h 55min
How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

 . 48min 13sec
From AlphaFold to MMseqs2-GPU: How AI is Accelerating Protein Science - Ep. 273
NVIDIA AI Podcast

Listen as two leading researchers at the cutting edge of computational biology explore breakthrough GPU accelerations that are changing how we understand life's molecular machinery. Chris Dallago, Research Lead at NVIDIA and Visiting Professor at Duke University, and Martin Stein ...  Show more

 . 34min 37sec